NO924995D0 - HUMANT MEG-CSF PROTEIN AND PROCEDURES - Google Patents

HUMANT MEG-CSF PROTEIN AND PROCEDURES

Info

Publication number
NO924995D0
NO924995D0 NO924995A NO924995A NO924995D0 NO 924995 D0 NO924995 D0 NO 924995D0 NO 924995 A NO924995 A NO 924995A NO 924995 A NO924995 A NO 924995A NO 924995 D0 NO924995 D0 NO 924995D0
Authority
NO
Norway
Prior art keywords
humant
meg
procedures
csf protein
csf
Prior art date
Application number
NO924995A
Other languages
Norwegian (no)
Other versions
NO924995L (en
Inventor
Martin J Murphy
Ralph E Parchment
Connie L Erickson-Miller
Wei Dai
Zhao-Geng Zhang
Lance A Liotta
Henry Krutzsch
Original Assignee
Hipple Cancer Res Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1991/004698 external-priority patent/WO1992000319A1/en
Application filed by Hipple Cancer Res Center filed Critical Hipple Cancer Res Center
Publication of NO924995D0 publication Critical patent/NO924995D0/en
Publication of NO924995L publication Critical patent/NO924995L/en

Links

NO92924995A 1990-07-02 1992-12-23 HUMANT MEG-CSF PROTEIN AND PROCEDURES NO924995L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54757390A 1990-07-02 1990-07-02
PCT/US1991/004698 WO1992000319A1 (en) 1990-07-02 1991-07-02 Human meg-csf protein and methods

Publications (2)

Publication Number Publication Date
NO924995D0 true NO924995D0 (en) 1992-12-23
NO924995L NO924995L (en) 1993-03-01

Family

ID=26783241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924995A NO924995L (en) 1990-07-02 1992-12-23 HUMANT MEG-CSF PROTEIN AND PROCEDURES

Country Status (1)

Country Link
NO (1) NO924995L (en)

Also Published As

Publication number Publication date
NO924995L (en) 1993-03-01

Similar Documents

Publication Publication Date Title
NO921863L (en) ANTIBODIES AND USES THEREOF
IS4481A (en) Dihydropyramidine and their use
DK91192D0 (en) PROTEIN
NO943511L (en) Pharmaceutical preparations and their use
NO961425D0 (en) 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
NO924321D0 (en) SYNERGISTIC THERAPEUTIC MIXTURES AND PROCEDURES
NO912589D0 (en) ANTI-PLACES AND ANTI-TUNSTEN DENTALS.
NO833659L (en) HUMANT IMMUN INTERFERON PROTEIN AND PROCEDURES THEREOF
FI952069A0 (en) Low allergenic proteins
NO971505D0 (en) Trophine and trophine helper proteins
FI934588A (en) INSULINLINE VAEXTFAKTOR BINDANDE PROTEIN HAERSTAMMANDE FRAON MAENNISKOBEN
DK0456138T3 (en) Peptide amidases and their use
NO893474L (en) FLAMMETIC AGENTS AND PROCEDURES FOR USE.
EP0540575A4 (en) Human meg-csf protein and methods
NO924995D0 (en) HUMANT MEG-CSF PROTEIN AND PROCEDURES
DK0460219T3 (en) Treated hemoglobin and preparation thereof
NO900271D0 (en) CONNECTION AND USE.
DE69434900D1 (en) HUMAN CHEMOKIN POLYPEPTIDE
DK8690D0 (en) CONNECTIONS AND USE
DK8590D0 (en) CONNECTIONS AND USE
DK36390D0 (en) CONNECTIONS AND USE
NO924293D0 (en) CYCLIZED AND LINEAR THERAPEUTIC PEPTIDES
DK251090D0 (en) ANTIBODIES AND USE THEREOF
DK120792D0 (en) PROTEIN
NO901828D0 (en) POROE POLYMERCULES AND PROCEDURES.